EMS Medical Direction Resources & Documents

Statements

• Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at this Time – Statement of Endorsement (NASEMSO, July 2024)
  NASEMSO, upon the recommendation of the NASEMSO Medical Directors Council, endorses the Joint Position Statement of the American College of Medical Toxicology and the American Academy of Clinical Toxicology: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at this Time.
  
• Clinical Care and Restraint of Agitated or Combative Patients by EMS Practitioners – Joint Position Statement (NAEMSP, NASEMSO, NEMSMA, NAEMT, APA; 2021)
  The National Association of EMS Physicians (NAEMSP) has had a position statement on patient restraint since 2002, which was updated in 2017. This document updates and replaces these previous statements and is now a joint position statement with NASEMSO, National EMS Management Association (NEMSMA), National Association of Emergency Medical Technicians (NAEMT), and the American Paramedic Association (APA).
  

Drug Shortages

• Drug Shortages in EMS–Coping Strategies & Best Practices (NASEMSO, 2014)
  An overview of strategies identified at the April 2014 EMS Drug Shortages Summit.

Survey Results

• State EMS Medical Directors–Understanding Current Roles & Job Landscape (NASEMSO, 2023)
  While most state EMS offices have a physician appointed to serve as the state EMS medical director, their employment arrangements, qualifications, duties, and compensation vary among states. The purpose of this survey, first conducted in 2007-08 and repeated in 2022-23, was intended to capture this information to assist in identifying commonalities, especially for states in the process of creating the position.